Emerging Insight into MAPK Inhibitors and Immunotherapy in Colorectal Cancer-Reference-Cited by-同舟云学术

Emerging Insight into MAPK Inhibitors and Immunotherapy in Colorectal Cancer

Published:2017-06-30 Issue:14 Volume:24 Page:
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

Pancione Massimo¹,Giordano Guido²,Parcesepe Pietro³,Cerulo Luigi⁴,Coppola Luigi⁵,Curatolo Anais Del⁶,Conciatori Fabiana⁶,Milella Michele⁶,Porras Almudena⁷

Affiliation:

1. Department of Sciences and Technologies, University of Sannio, Via Port'Arsa, 1182100 Benevento, Italy

2. CRO Aviano National Cancer Center, Aviano, Italy

3. Department of Diagnostics and Public Health – Section of Pathology, University and Hospital Trust of Verona, 31134 Verona, Italy

4. Department of Science and Technology, University of Sannio, Benevento, Italy

5. Medical Oncology and Anatomic Pathology Unit, San Filippo Neri Hospital, Rome, Italy

6. Division of Medical Oncology A, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy

7. Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, Complutense University, Madrid, Spain

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of expression profiles and prognostic value of RFCs in colorectal cancer;Scientific Reports;2024-03-19

2. Activation of CHPF by transcription factor NFIC promotes NLRP3 activation during the progression of colorectal cancer;Functional & Integrative Genomics;2024-01-24

3. The opportunities and challenges in immunotherapy: Insights from the regulation of PD-L1 in cancer cells;Cancer Letters;2023-08

4. Zearalenone attenuates colitis associated colorectal tumorigenesis through Ras/Raf/ERK pathway suppression and SCFA-producing bacteria promotion;Biomedicine & Pharmacotherapy;2023-08

5. Identification of Novel miRNAs, Targeting Genes, Signaling Pathway, and the Small Molecule for Overcoming Oxaliplatin Resistance of Metastatic Colorectal Cancer;BioMed Research International;2022-09-19